2008

  • Aremed® was launched in Cyprus and Eastern Europe climbing straight into the company’s top 10 pharmaceutical products by sales value.
  • In addition, the following products were registered: Melorem® (Meloxicam), an anti-inflammatory, antirheumatic drug, Petilin® Syrup (Sodium Valproate), an anticonvulsant drug, Glizorem® (Gliclazide), an anti-diabetic,Nifelat® LA (Nifedipine), a calcium channel blocker, Clozarem® (Clozapine), an neuroleptic (antipsychotic), and Cilotral® (Citalopram), a potent serotonin re-uptake inhibitor.
  • Remedica also launched its Newsletter that aims to inform its associates – both internal and external – of ongoing developments.